A study published by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) demonstrated high diagnostic accuracy for PreventID® Dermatophyte, which the authors considered an easy-to-use adjunct for suspected tinea unguium.
In a study conducted by the German Cancer Research Center (DKFZ), Preventis SmarTest® FIT Home demonstrated diagnostic performance comparable to the lab in detecting advanced neoplasms. Performed by lay users at home, it achieved higher user acceptance.
In a comparative study of at-home and laboratory tests, Preventis SmarTest® Calprotectin Home stood out for its ease of use, intuitive user interface, and results comparable to laboratory testing.
Preventis’ quantitative at-home test, SmarTest® Calprotectin Home, demonstrated an overall diagnostic accuracy of 92.80% in a comparative study with the LIAISON XL system for measuring fecal calprotectin, a marker of intestinal inflammation.
In a validation study involving 79 patients with IBD, Preventis SmarTest® Vitamin D showed a strong correlation with an established ELISA method and delivered comparable 25(OH)D results.